Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
HOTAIR inhibitor
DRUG CLASS:
HOTAIR inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
AC1Q3QWB (2)
AC1Q3QWB (2)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
SOX17 overexpression
Endometrial Cancer
SOX17 overexpression
Endometrial Cancer
tazemetostat + AC1Q3QWB
Sensitive: D – Preclinical
tazemetostat + AC1Q3QWB
Sensitive
:
D
tazemetostat + AC1Q3QWB
Sensitive: D – Preclinical
tazemetostat + AC1Q3QWB
Sensitive
:
D
CDKN1A overexpression
Endometrial Cancer
CDKN1A overexpression
Endometrial Cancer
tazemetostat + AC1Q3QWB
Sensitive: D – Preclinical
tazemetostat + AC1Q3QWB
Sensitive
:
D
tazemetostat + AC1Q3QWB
Sensitive: D – Preclinical
tazemetostat + AC1Q3QWB
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login